There’s been a growing interest in this product ever since it was introduced. And it’s no wonder. LATISSE® is the first and only Health Canada and FDA-approved prescription treatment for inadequate or not enough eyelashes, growing them longer, fuller and darker.
LATISSE® makes lash growth possible because of its active ingredient: bimatoprost.
Although the precise mechanism of action is unknown. LATISSE® is believed to affect the growth (anagen) phase of the eyelash hair cycle in two ways; first, it increases the length of this phase, and second, it increases the number of hairs in this growth phase.
Although LATISSE® is a treatment for inadequate or not enough eyelashes, it was developed through years of research by Allergan, a pharmaceutical leader with expertise in eye care products.